ConditionMuscle Relaxation
Trial statusRecruiting
Trial phasePhase 2, Phase 3
Trial typeInterventional
Biological sexAll
Age18-60
SponsorAssiut University
About this trial
In this study, the effect of magnesium sulphate on the onset and duration of intense and moderate cis-atracurium induced neuromuscular blocking and on the period of no response to nerve stimulation will be evaluated in patients who will recieve magnesium sulphate (intervention group) and patients who will not recieve magnesium sulphate (comparator group).
Eligibility criteria
Qualifiers
Age group 18-60 years old
Both genders
Patients who will be scheduled to undergo elective otorhinolaryngological surgery.
Patients with BMI between 18.5 and 24.9 Kg/m2.
Disqualifiers
Patients who are less than 18 years old or more than 60 years old.
Patients on medications that interfered with muscle activity.
Allergy to medications used in this study.
Pregnancy or suspected pregnancy.
Trial design
Treatments tested in this trial
- Magnesium Sulphate
- Saline
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov